Identification of potential antiatherosclerotic/hypolipidemic agents by their effect on hepatic conversion of androst-4-ene-3,17-dione to etiocholanolone and androsterone
- 31 January 1985
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 54 (1) , 23-36
- https://doi.org/10.1016/0021-9150(85)90150-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effects of altered endocrine function on biliary metabolites of [4-14C]androst-4-ene-3,17-dione in ratsAtherosclerosis, 1985
- Induction of a deficiency of steroid delta 4-5 alpha-reductase activity in liver by a porphyrinogenic drug.Journal of Clinical Investigation, 1977
- Androgen metabolism by rat epididymis: 1. Metabolic conversion of 3H-testosteroneSteroids, 1973
- The Biological Properties of EtiocholanoloneAnnals of Internal Medicine, 1967
- The Determination of Collagen and ElastinPublished by Wiley ,1967
- Metabolism of llβ-Hydroxy-Δ4-androstene-3,17-dione: Effect of Thyroid HormoneJournal of Clinical Endocrinology & Metabolism, 1966
- Thyroid and Steroid Hormones and Their Relation to Serum Lipid Concentrations in ManJournal of Clinical Endocrinology & Metabolism, 1966
- Androgen Metabolism in Patients with Hypercholesteremia and Coronary Artery DiseaseJAMA, 1963
- THE EFFECTS OF THYROID HORMONES ON THE METABOLISM OF STEROIDS*Annals of the New York Academy of Sciences, 1960
- THYROID-ANDROGEN INTERRELATIONS AND THE HYPOCHOLESTEREMIC EFFECT OF ANDROSTERONE*Journal of Clinical Endocrinology & Metabolism, 1959